In conclusion, our study showed that expression of the TRAF6 and NFKB1 genes and miRNAs in monocytes do not play a role in the development and pathogenesis of RA, although miR-194-5p and miR-9-5p levels showed differences in patients with different RA treatment strategy. This evidence concerns the gene NFKB1 and rheumatoid arthritis.